Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
This is Omeza’s first Rx product and the first drug/device combination matrix of its kind for chronic wound care
The product will be available in 500 mg/2.5 mL and 1 g/5 mL vials
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
The drug is indicated for mild and transient episodes of heart block
Filing for WHO Emergency Use Authorisation this month
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
The Cephalosporin Injectables plant has a total capacity of 26.4 million vials per year while Ethiopia is having a demand for 16 million vials
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
